 |
 |
 |
|
Reduction in estimated Glomerular Filtration Rate (eGFR) Observed With Doravirine (DOR) is Caused by Inhibition of Organic Cation Transporter 2 (OCT2)
|
|
|
HIV Drug Therapy Glasgow; Glasgow, UK; 10-13 November, 2024.
Yang Li1; Xiaoyan Chu1; Rosa I. Sanchez1; Russ P. Carstens2; Mary L. Pisculli2;
Stephanie Klopfer3; Zhi Jin Xu3;
Rima Lahoulou4; Rebeca M. Plank2*
1Pharmacokinetics, Merck & Co., Inc., Rahway, NJ, USA; 2Clinical Research, Merck & Co., Inc., Rahway, NJ, USA; 3Biostatistics, Merck & Co., Inc., Rahway, NJ, USA; 4MSD France, Puteaux, France
*Presenting author




|
|
|
 |
 |
|
|